Cargando…
Response of Mycobacterium smegmatis to the Cytochrome bcc Inhibitor Q203
For the design of next-generation tuberculosis chemotherapy, insight into bacterial defence against drugs is required. Currently, targeting respiration has attracted strong attention for combatting drug-resistant mycobacteria. Q203 (telacebec), an inhibitor of the cytochrome bcc complex in the mycob...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498996/ https://www.ncbi.nlm.nih.gov/pubmed/36142240 http://dx.doi.org/10.3390/ijms231810331 |